首页 > 最新文献

Journal of Radiation and Cancer Research最新文献

英文 中文
Study on Dosimetric Superiority of Forward Planned Intensity-Modulated Radiotherapy Treatment of Thoracic Esophageal Squamous Cell Carcinoma 前计划调强放疗治疗胸段食管鳞状细胞癌剂量学优势研究
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_71_22
S. Rather, M. Banday, S. Wani, Aijaz A. Khan, M. Shah, T. Tali, F. Mir, M. A. Badhul Haq
{"title":"Study on Dosimetric Superiority of Forward Planned Intensity-Modulated Radiotherapy Treatment of Thoracic Esophageal Squamous Cell Carcinoma","authors":"S. Rather, M. Banday, S. Wani, Aijaz A. Khan, M. Shah, T. Tali, F. Mir, M. A. Badhul Haq","doi":"10.4103/jrcr.jrcr_71_22","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_71_22","url":null,"abstract":"","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75750087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Different Evaluation Indexes for Postoperative Brain Cancer Radiation Therapy Plans: Conformity Index, Homogeneity Index, and Total Coverage Index 脑癌术后放疗方案不同评价指标的分析:符合性指数、均匀性指数和总覆盖指数
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_91_22
S. Rather, M. Banday, Samina Mufti, MustaqAhmad Sofi, MisbhaHamid Baba
{"title":"Analysis of Different Evaluation Indexes for Postoperative Brain Cancer Radiation Therapy Plans: Conformity Index, Homogeneity Index, and Total Coverage Index","authors":"S. Rather, M. Banday, Samina Mufti, MustaqAhmad Sofi, MisbhaHamid Baba","doi":"10.4103/jrcr.jrcr_91_22","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_91_22","url":null,"abstract":"","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79759291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Augmented Immune-Staining of G-Quadruplex Tertiary DNA Structure in Chemo-Tolerant TNBC with Downregulation of WNT/Epidermal Growth Factor Receptor Pathway receptor Genes: A Pilot Clinicopathological Study 耐化疗TNBC中g -四联体三级DNA结构增强免疫染色与WNT/表皮生长因子受体通路受体基因下调的关联:一项初步临床病理研究
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_23_22
Saimul Islam, Mukta Basu, A. Roy, N. Alam, C. Panda
Purpose: The aim of the study is to understand the involvement of G-Quadruplex (G-Q) structures in altering the expression profile of WNT/epidermal growth factor receptor (EGFR) pathway receptor genes in chemo-tolerant Triple Negative Breast Cancer (TNBC) samples. Materials and Methods: At first, Gene Expression Omnibus datasets were mined where the expression profile of WNT/EGFR pathway genes in TNBC samples and MDA-MB-231, a TNBC cell line, were checked in response to doxorubicin, a chemotherapeutic drug. Next, to unveil the probable mechanism of regulation, the presence of G-Q structure was checked in in silico study and later validated by immunohistochemical analyses in our pool of sample. These observed results were correlated with patient's demography and survival status. Results: Expression of the receptors (FZD7, LRP6, EGFR) of the WNT/EGFR pathway were found to be differentially expressed in TNBC samples; further emphasized in our samples (n = 61). Notably, these G-Q structures were found in the promoter region of the WNT pathway receptor genes (FZD7, LRP6, and EGFR). Validating in our patient sample pool, a significant increase in G-Q immunostaining was observed in samples, after neoadjuvant chemotherapy (NACT) samples (n = 17) than the pretherapeutic samples (n = 44). Similar pattern of G-Q immunostaining was noticed in doxorubicin-treated MDA-MB-231 cell line. Intriguingly, low staining of G-Q among the pretherapeutic samples, but NACT TNBC samples, was found to be significantly correlated with lymph node metastasis. Conclusions: This study showed that the augmented immunostaining of G-Q structure might have an important involvement in regulating the expression pattern of the WNT/EGFR pathway genes in response to doxorubicin treatment of TNBC.
目的:本研究旨在了解g -四重体(G-Q)结构在改变耐药三阴性乳腺癌(TNBC)样本中WNT/表皮生长因子受体(EGFR)通路受体基因表达谱中的作用。材料和方法:首先,挖掘基因表达Omnibus数据集,其中检查TNBC样本和MDA-MB-231 (TNBC细胞系)中WNT/EGFR通路基因的表达谱,以响应阿霉素(一种化疗药物)。接下来,为了揭示可能的调节机制,我们在硅研究中检查了G-Q结构的存在,随后在我们的样本池中通过免疫组织化学分析进行了验证。这些观察结果与患者的人口统计学和生存状态相关。结果:WNT/EGFR通路受体FZD7、LRP6、EGFR在TNBC中存在差异表达;在我们的样本(n = 61)中进一步强调。值得注意的是,这些G-Q结构位于WNT通路受体基因(FZD7、LRP6和EGFR)的启动子区域。在我们的患者样本池中,新辅助化疗(NACT)后样本(n = 17)的G-Q免疫染色明显高于治疗前样本(n = 44)。在阿霉素处理的MDA-MB-231细胞系中,G-Q免疫染色也出现了类似的模式。有趣的是,治疗前样品中G-Q的低染色,但NACT TNBC样品,被发现与淋巴结转移显著相关。结论:本研究表明,G-Q结构的增强免疫染色可能在多柔比星治疗TNBC后,对WNT/EGFR通路基因表达模式的调节中起重要作用。
{"title":"Association of Augmented Immune-Staining of G-Quadruplex Tertiary DNA Structure in Chemo-Tolerant TNBC with Downregulation of WNT/Epidermal Growth Factor Receptor Pathway receptor Genes: A Pilot Clinicopathological Study","authors":"Saimul Islam, Mukta Basu, A. Roy, N. Alam, C. Panda","doi":"10.4103/jrcr.jrcr_23_22","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_23_22","url":null,"abstract":"Purpose: The aim of the study is to understand the involvement of G-Quadruplex (G-Q) structures in altering the expression profile of WNT/epidermal growth factor receptor (EGFR) pathway receptor genes in chemo-tolerant Triple Negative Breast Cancer (TNBC) samples. Materials and Methods: At first, Gene Expression Omnibus datasets were mined where the expression profile of WNT/EGFR pathway genes in TNBC samples and MDA-MB-231, a TNBC cell line, were checked in response to doxorubicin, a chemotherapeutic drug. Next, to unveil the probable mechanism of regulation, the presence of G-Q structure was checked in in silico study and later validated by immunohistochemical analyses in our pool of sample. These observed results were correlated with patient's demography and survival status. Results: Expression of the receptors (FZD7, LRP6, EGFR) of the WNT/EGFR pathway were found to be differentially expressed in TNBC samples; further emphasized in our samples (n = 61). Notably, these G-Q structures were found in the promoter region of the WNT pathway receptor genes (FZD7, LRP6, and EGFR). Validating in our patient sample pool, a significant increase in G-Q immunostaining was observed in samples, after neoadjuvant chemotherapy (NACT) samples (n = 17) than the pretherapeutic samples (n = 44). Similar pattern of G-Q immunostaining was noticed in doxorubicin-treated MDA-MB-231 cell line. Intriguingly, low staining of G-Q among the pretherapeutic samples, but NACT TNBC samples, was found to be significantly correlated with lymph node metastasis. Conclusions: This study showed that the augmented immunostaining of G-Q structure might have an important involvement in regulating the expression pattern of the WNT/EGFR pathway genes in response to doxorubicin treatment of TNBC.","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78607597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remembering Dr. Bam Bahadur Singh: An outstanding Scientist and a learned lawyer 纪念巴姆·巴哈杜尔·辛格博士:一位杰出的科学家和一位博学的律师
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_9_23
KP Mishra
{"title":"Remembering Dr. Bam Bahadur Singh: An outstanding Scientist and a learned lawyer","authors":"KP Mishra","doi":"10.4103/jrcr.jrcr_9_23","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_9_23","url":null,"abstract":"","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82615987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An observational study of diffusion-wssseighted imaging characteristics in patients with cervical cancer 宫颈癌患者弥漫性影像特征的观察研究
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_22_23
Hitesh Sinduriyan, Rachit Sharma, GauravPratap Singh Gahlot
{"title":"An observational study of diffusion-wssseighted imaging characteristics in patients with cervical cancer","authors":"Hitesh Sinduriyan, Rachit Sharma, GauravPratap Singh Gahlot","doi":"10.4103/jrcr.jrcr_22_23","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_22_23","url":null,"abstract":"","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76742950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of physical activity and exercise in cancer patients: A review on exercise oncology 体育活动和运动对癌症患者的意义:运动肿瘤学研究综述
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_57_22
J. Dar, T. Tali, Fiza Amin, NazirAhmad Khan, N. Dar
{"title":"Significance of physical activity and exercise in cancer patients: A review on exercise oncology","authors":"J. Dar, T. Tali, Fiza Amin, NazirAhmad Khan, N. Dar","doi":"10.4103/jrcr.jrcr_57_22","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_57_22","url":null,"abstract":"","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79739261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasmacytoma of nasopharynx - A rare case presentation treated with volumetric modulated arc technique radiotherapy 鼻咽部浆细胞瘤-用体积调制弧线技术放射治疗的罕见病例
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_6_22
Sujata Sarkar, I. Bashir, R. Yotham, Ritesh Sharma
Extramedullary plasmacytomas (EMPs) are solitary plasma cell neoplasms that involve sites other than bone or bone marrow. It constitutes only 0.4% of tumors of head-and-neck region. Surgery and radiotherapy are standard treatment, depending on the site. Radiotherapy promises 90–100% local control rate and prolonged survival. Here, we are reporting a case of plasmacytoma nasopharynx treated with volumetric-modulated arc technique (VMAT) radiotherapy, with contouring details, dose to target, and nearby structures. Patient had complete response and is relapse free for the past 3 years with minimal toxicity. In our case, the lesion is in nasopharynx and is about 1cm, as such it required precise radiotherapy technique like VMAT, to give targeted dose delivery and sparing the nearby critical organs.
髓外浆细胞瘤(EMPs)是孤立的浆细胞肿瘤,累及骨或骨髓以外的部位。仅占头颈部肿瘤的0.4%。手术和放疗是标准的治疗方法,视部位而定。放疗可保证90-100%的局部控制率和延长生存期。在此,我们报告一例采用体积调制电弧技术(VMAT)放射治疗的鼻咽部浆细胞瘤,包括轮廓细节、靶剂量和附近结构。患者完全缓解,在过去3年无复发,毒性最小。在我们的病例中,病变位于鼻咽部,约1cm,因此需要精确的放射治疗技术,如VMAT,给予靶向剂量,并保留附近的关键器官。
{"title":"Plasmacytoma of nasopharynx - A rare case presentation treated with volumetric modulated arc technique radiotherapy","authors":"Sujata Sarkar, I. Bashir, R. Yotham, Ritesh Sharma","doi":"10.4103/jrcr.jrcr_6_22","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_6_22","url":null,"abstract":"Extramedullary plasmacytomas (EMPs) are solitary plasma cell neoplasms that involve sites other than bone or bone marrow. It constitutes only 0.4% of tumors of head-and-neck region. Surgery and radiotherapy are standard treatment, depending on the site. Radiotherapy promises 90–100% local control rate and prolonged survival. Here, we are reporting a case of plasmacytoma nasopharynx treated with volumetric-modulated arc technique (VMAT) radiotherapy, with contouring details, dose to target, and nearby structures. Patient had complete response and is relapse free for the past 3 years with minimal toxicity. In our case, the lesion is in nasopharynx and is about 1cm, as such it required precise radiotherapy technique like VMAT, to give targeted dose delivery and sparing the nearby critical organs.","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74965428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synchronous squamous cell carcinoma of the hypopharynx and adenocarcinoma of the lung: A report of two cases treated with definitive radiotherapy 下咽同步鳞状细胞癌伴肺腺癌:2例放疗治疗报告
Pub Date : 2023-01-01 DOI: 10.4103/jrcr.jrcr_13_23
J. Nath, M. Bhattacharyya, Saswati Datta, Shiraj Ahmed, J. Das, Yanpothung Yanthan
{"title":"Synchronous squamous cell carcinoma of the hypopharynx and adenocarcinoma of the lung: A report of two cases treated with definitive radiotherapy","authors":"J. Nath, M. Bhattacharyya, Saswati Datta, Shiraj Ahmed, J. Das, Yanpothung Yanthan","doi":"10.4103/jrcr.jrcr_13_23","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_13_23","url":null,"abstract":"","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89835568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excitements in radiobiology 放射生物学的兴奋
Pub Date : 2022-10-01 DOI: 10.4103/jrcr.jrcr_76_22
KP Mishra
{"title":"Excitements in radiobiology","authors":"KP Mishra","doi":"10.4103/jrcr.jrcr_76_22","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_76_22","url":null,"abstract":"","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90877414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changing treatment paradigms of radiotherapy for the treatment of lung cancer 改变放疗治疗肺癌的治疗模式
Pub Date : 2022-10-01 DOI: 10.4103/jrcr.jrcr_5_22
Atsuto Katano
Lung cancer is largely classified into two types according to its histology, small cell and nonsmall cell, and has diverse situations for which radiotherapy is indicated. Radiation therapy plays a major role in the treatment strategy for both types of lung cancer. Since the treatment of lung cancer is extremely complex, it is essential to develop an appropriate treatment strategy by combining surgery, radiotherapy, and systemic therapy (chemotherapy, immunotherapy, and molecular-targeted drugs) according to each stage of the disease. Radiotherapy is indicated, from curative intent to palliative treatment, at any stage of the disease. Current radiotherapy, which incorporates diagnostic imaging and physical engineering, has made significant progress, making it possible to increase the local control rate while reducing the radiation dose to at-risk organs. Herein, we review the basics of the current perspective of radiotherapy and the current role of radiotherapy in lung cancer treatment according to each stage of the disease.
肺癌根据其组织学大致分为小细胞和非小细胞两种类型,需要放疗的情况也多种多样。放射治疗在两种类型肺癌的治疗策略中起着重要作用。由于肺癌的治疗极为复杂,必须根据疾病的各个阶段制定合适的治疗策略,结合手术、放疗和全身治疗(化疗、免疫治疗和分子靶向药物)。从治疗目的到姑息治疗,在疾病的任何阶段都需要放射治疗。目前的放射治疗,结合了诊断成像和物理工程,已经取得了重大进展,使其有可能提高局部控制率,同时减少对危险器官的辐射剂量。在此,我们将根据疾病的各个阶段,对目前放疗的基本观点和放疗在肺癌治疗中的作用进行综述。
{"title":"Changing treatment paradigms of radiotherapy for the treatment of lung cancer","authors":"Atsuto Katano","doi":"10.4103/jrcr.jrcr_5_22","DOIUrl":"https://doi.org/10.4103/jrcr.jrcr_5_22","url":null,"abstract":"Lung cancer is largely classified into two types according to its histology, small cell and nonsmall cell, and has diverse situations for which radiotherapy is indicated. Radiation therapy plays a major role in the treatment strategy for both types of lung cancer. Since the treatment of lung cancer is extremely complex, it is essential to develop an appropriate treatment strategy by combining surgery, radiotherapy, and systemic therapy (chemotherapy, immunotherapy, and molecular-targeted drugs) according to each stage of the disease. Radiotherapy is indicated, from curative intent to palliative treatment, at any stage of the disease. Current radiotherapy, which incorporates diagnostic imaging and physical engineering, has made significant progress, making it possible to increase the local control rate while reducing the radiation dose to at-risk organs. Herein, we review the basics of the current perspective of radiotherapy and the current role of radiotherapy in lung cancer treatment according to each stage of the disease.","PeriodicalId":16923,"journal":{"name":"Journal of Radiation and Cancer Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87867334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Radiation and Cancer Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1